EFG - ETF AI Analysis
Top Page
iShares MSCI EAFE Growth ETF (EFG)
Rating:65Neutral
Price Target:―
Positive Factors
Strong Leading Holdings
Key positions like ASML, Tokyo Electron, and several industrial names have shown strong gains, helping drive the ETF’s overall performance.
Broad International Diversification
The fund spreads its investments across many developed markets such as Japan, the UK, Europe, and Australia, reducing reliance on any single country.
Growth-Focused Exposure
A tilt toward growth-oriented sectors like technology, industrials, and health care offers potential for long-term capital appreciation.
Negative Factors
Concentration in a Few Large Positions
The largest holdings, especially ASML, make up a meaningful share of the portfolio, increasing the impact if any of these companies stumble.
Mixed Performance Among Top Holdings
Some major positions, such as AstraZeneca and SAP, have shown weak or lagging performance, which can offset gains from stronger names.
Limited U.S. Market Exposure
With only a small portion of assets in U.S. stocks, the ETF may lag broader global benchmarks when the U.S. market is leading.
EFG vs. SPDR S&P 500 ETF (SPY)
AUM16.74B
RegionDeveloped Markets
Expense Ratio0.36%
Beta0.93
IssueriShares
Inception DateAug 01, 2005
Dividend Yield2.3%
Asset ClassEquity
Index TrackedMSCI EAFE Growth
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume771,250
30 Day Avg. Volume886,135
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
146.54Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering352
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
EFG Summary
The iShares MSCI EAFE Growth ETF (EFG) is a fund that follows the MSCI EAFE Growth Index, focusing on fast-growing companies in developed markets outside the U.S. and Canada, such as Japan, the UK, and Europe. It holds well-known international names like ASML Holding and AstraZeneca, spread across sectors like technology, industrials, and finance. Investors might consider EFG to add global diversification and tap into long-term growth from overseas companies. However, its value can go up and down with global stock markets and may be especially sensitive to swings in growth-focused stocks.
How much will it cost me?The iShares MSCI EAFE Growth ETF (EFG) has an expense ratio of 0.36%, meaning you’ll pay $3.60 per year for every $1,000 invested. This cost is slightly higher than average for ETFs because it tracks a growth-focused index, which requires more active management compared to broad, passively managed funds. It’s still considered reasonable for the specialized exposure it provides.
What would affect this ETF?The iShares MSCI EAFE Growth ETF could benefit from continued innovation and expansion in technology and industrial sectors, which make up a significant portion of its holdings. However, challenges like rising interest rates or economic slowdowns in developed markets outside North America could negatively impact growth-focused companies. Additionally, regulatory changes or geopolitical tensions in regions like Europe or Asia may affect the ETF’s performance.
EFG Top 10 Holdings
EFG leans heavily on international growth stars, with chip-equipment leaders ASML and Tokyo Electron doing much of the heavy lifting as their shares keep rising over the year, giving the fund a strong semiconductor backbone. European industrial names like Schneider Electric and ABB have been mostly supportive, though their momentum has turned a bit mixed lately. On the flip side, SAP has been losing steam and AstraZeneca has been lagging, acting as mild brakes on performance. Overall, the ETF is a developed-markets play outside North America, anchored in Europe and Asia.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 5.91% | $988.06M | €550.06B | 141.04% | 76 Outperform | |
| AstraZeneca | 2.39% | $400.22M | $265.97B | 13.76% | 80 Outperform | |
| Commonwealth Bank of Australia | 1.94% | $325.01M | AU$298.00B | 1.41% | 64 Neutral | |
| SAP SE | 1.74% | $290.13M | €182.05B | -35.51% | 66 Neutral | |
| Schneider Electric | 1.67% | $278.50M | €160.72B | 34.08% | 62 Neutral | |
| UBS Group AG | 1.56% | $261.35M | $159.77B | 43.82% | 73 Outperform | |
| Rolls-Royce Holdings | 1.54% | $256.98M | £121.92B | 37.77% | 71 Outperform | |
| ― | 1.53% | $255.92M | ― | ― | ― | |
| ABB Ltd | 1.42% | $237.49M | kr1.67T | 48.01% | 78 Outperform | |
| Tokyo Electron | 1.41% | $236.50M | ¥23.75T | 126.39% | 73 Outperform |
EFG Technical Analysis
Positive
―
Price Trends
121.69
Negative
118.70
Positive
116.90
Positive
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For EFG, the sentiment is Positive. The current price of undefined is equal to the 20-day moving average (MA) of 120.98, equal to the 50-day MA of 121.69, and equal to the 200-day MA of 116.90, indicating a neutral trend. The MACD of ― indicates undefined momentum. The RSI at ― is undefined, neither overbought nor oversold. The STOCH value of ― is undefined, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for EFG.
EFG Peer Comparison
Comparison Results
Performance Comparison
EFG
iShares MSCI EAFE Growth ETF
121.42
15.41
14.54%
IEFA
iShares Core MSCI EAFE ETF
―
―
―
EFA
iShares MSCI EAFE ETF
―
―
―
EFV
iShares MSCI EAFE Value ETF
―
―
―
ESGD
iShares ESG Aware MSCI EAFE ETF
―
―
―
JIRE
JPMorgan International Research Enhanced Equity ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents